News
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 10, 2020Clinical Stage Cell Therapy Company Reports Concurrent Modulation of T Regulatory Cells and Tolerogenic Dendritic Cells using Adoptive Cellular Therapy
Creative Medical Technology Holdings trading under the ticker symbol CELZ announced today its patent filing based on data covering utilization of the Company's ImmCelz ® product at generating...
-
Sep 29, 2020Commercial Stage Stem Cell Company Achieves Selective Reprogramming of Pathological Autoimmunity
(OTC-CELZ) -- Creative Medical Technology Holdings announced today proof of concept studies demonstrating efficacy of its ImmCelz ® immunotherapy product in the collage induced model of...
-
Sep 24, 2020
(OTC-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its corporate activities. CaverStemR: Recruitment and training of physicians on the CaverStemR program for the...
-
Sep 8, 2020Commercial Stage Stem Cell Company Receives Second Patent Issuance Covering Cell Therapies for Disc Inflammation and Degeneration
(OTC – CELZ) -- Creative Medical Technology Holdings Inc. announced today receipt of a Notice of Allowance from the United States Patent and Trademark Office for its patent application,...
-
Aug 20, 2020New Data Supports Current Push for FDA Clearance of Universal Donor Amniotic Fluid Derived Stem Cell Product
Creative Medical Technology Holdings Inc., trading under the ticker symbol CELZ, announced today new data demonstrating effective suppression of stroke associated pathological molecules by...